hemangiol
pierre fabre medicament - propranolol-hydrochloridu - hemangiom - beta-blokátory - hemangiol is indicated in the treatment of proliferating infantile haemangioma requiring systemic therapy: , life- or function-threatening haemangioma,, ulcerated haemangioma with pain and/or lack of response to simple wound care measures,, haemangioma with a risk of permanent scars or disfigurement. , it is to be initiated in infants aged 5 weeks to 5 months.
metoprolol ratiopharm 100 mg
ratiopharm gmbh, nemecko - metoprolol - 58 - hypotensiva
betaloc zok 100 mg
recordati industria chimica e farmaceutica s.p.a., taliansko - metoprolol - 58 - hypotensiva
betaloc zok 50 mg
recordati industria chimica e farmaceutica s.p.a., taliansko - metoprolol - 58 - hypotensiva
betaloc zok 25 mg
recordati industria chimica e farmaceutica s.p.a., taliansko - metoprolol - 58 - hypotensiva
corvitol 50
berlin-chemie ag, nemecko - metoprolol - 77 - sympatholytica
egilok xl 50 mg
egis pharmaceuticals plc, maďarsko - metoprolol - 58 - hypotensiva
egilok xl 100 mg
egis pharmaceuticals plc, maďarsko - metoprolol - 58 - hypotensiva
egilok xl 200 mg
egis pharmaceuticals plc, maďarsko - metoprolol - 58 - hypotensiva
vasocardin 50
zentiva a.s., slovensko - metoprolol - 41 - cardiaca